Immunic, Inc. (IMUX) vs Inovio Pharmaceuticals, Inc. (INO)

Immunic, Inc. and Inovio Pharmaceuticals, Inc. are both Biotechnology companies. Immunic, Inc. and Inovio Pharmaceuticals, Inc. are of similar size ($127.2M and $126.9M). Across the 9 metrics below, Immunic, Inc. leads on 7 and Inovio Pharmaceuticals, Inc. on 2.

Valuation

Metric IMUX INO Biotechnology median
P/E n/m n/m 7.88
P/S n/m 249.64 11.47
P/B 3.12 22.03 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m 183.59 10.73
Earnings yield (46.84%) (77.12%) (28.84%)
Free cash flow yield (22.15%) (83.14%) (23.03%)

Profitability

Metric IMUX INO Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (138.17%) (409.87%) (57.72%)
Return on assets (101.15%) (114.64%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric IMUX INO Biotechnology median
Revenue growth (TTM) — (54.82%) 5.64%
EPS growth (last fiscal year) 38.00% 54.18% —
Revenue growth, 5-year CAGR — (61.18%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IMUX INO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.05 1.00 4.73
Net debt to EBITDA 0.15 0.70 0.96

Dividend

Metric IMUX INO Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric IMUX INO Biotechnology median
Market cap 127.17m 126.89m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack